This document intends to provide clarity on SAHPRA’s Core Business Escalation procedure, to enable effective and efficient communication between SAHPRA and its stakeholders....
This communication to industry was developed to express SAHPRA’s view that the therapeutic use of yohimbine in animals may be in the public interest and to outline the steps that SAHPRA is taking to place the product in the schedules....
This communication is intended to seek stakeholder input in gathering scientific information regarding the use of yohimbine in veterinary medicine....
This document provides guidance on access to unregistered medicines for animal use through the provisions of Section 21 of the Medicines and Related Substances Act, 1965 (Act 101 of 1965). Applicants are required to comply with the provisions of the Act and Regulations....
Request For Use of An Unregistered Product In Terms of Section 21 of Act 101 of 1965...
This guideline is intended to provide recommendations to applicants wishing to submit applications for the registration of veterinary medicines. ...
Kindly be advised that applicants may track the progress of their new veterinary medicine registration applications on the SAHPRA website....
This document should be completed by the applicant to ensure the inclusion of all necessary Bioequivalence Trial information....
Residues Overall Summary (ROS) should be completed for pharmaceutical products intended for food producing species....